Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
74.1M
-
Number of holders
-
160
-
Total 13F shares, excl. options
-
68.2M
-
Shares change
-
+2.54M
-
Total reported value, excl. options
-
$580M
-
Value change
-
+$18.2M
-
Put/Call ratio
-
1.81
-
Number of buys
-
83
-
Number of sells
-
-78
-
Price
-
$8.51
Significant Holders of Zymeworks Inc. - Common Stock, par value $0.00001 per share (ZYME) as of Q2 2024
192 filings reported holding ZYME - Zymeworks Inc. - Common Stock, par value $0.00001 per share as of Q2 2024.
Zymeworks Inc. - Common Stock, par value $0.00001 per share (ZYME) has 160 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 68.2M shares
of 74.1M outstanding shares and own 92% of the company stock.
Largest 10 shareholders include EcoR1 Capital, LLC (13.4M shares), BVF INC/IL (5.87M shares), Redmile Group, LLC (5.21M shares), MORGAN STANLEY (4.24M shares), BlackRock Inc. (4.19M shares), Rubric Capital Management LP (3.92M shares), VANGUARD GROUP INC (2.7M shares), DEUTSCHE BANK AG\ (2.36M shares), BNP PARIBAS ASSET MANAGEMENT Holding S.A. (1.93M shares), and UBS ASSET MANAGEMENT AMERICAS LLC (1.9M shares).
This table shows the top 160 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.